PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1804.99%
Both yoy net incomes decline, with CRON.TO at -263.17%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-2.82%
Both reduce yoy D&A, with CRON.TO at -12.00%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-210.31%
Negative yoy deferred tax while CRON.TO stands at 169.07%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-18.66%
Both cut yoy SBC, with CRON.TO at -68.89%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
83.67%
Slight usage while CRON.TO is negative at -433.10%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
213.16%
AR growth while CRON.TO is negative at -25.57%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
55.06%
Some inventory rise while CRON.TO is negative at -274.70%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-105.54%
Both negative yoy AP, with CRON.TO at -95.66%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
3.34%
Lower 'other working capital' growth vs. CRON.TO's 163.50%. David Dodd would see fewer unexpected short-term demands on cash.
386.89%
Some yoy increase while CRON.TO is negative at -158.40%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
90.83%
Some CFO growth while CRON.TO is negative at -37.40%. John Neff would note a short-term liquidity lead over the competitor.
37.83%
Some CapEx rise while CRON.TO is negative at -31.61%. John Neff would see competitor possibly building capacity while we hold back expansions.
319.83%
Acquisition spending well above CRON.TO's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
103.42%
Purchases well above CRON.TO's 100.00%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-116.21%
Both yoy lines are negative, with CRON.TO at -712.20%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
3144.44%
Growth well above CRON.TO's 1029.45%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
105.19%
We have mild expansions while CRON.TO is negative at -788.38%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-24.59%
We cut debt repayment yoy while CRON.TO is 17.78%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-103.42%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.